A
AIM ImmunoTech Inc. (AIM)
ASE – Real vaqt narxi. Valyuta: USD
0.28
+0.02 (7.83%)
Yopilishda: Aug 5, 2026, 4:00 PM EDT
0.30
+0.02 (5.82%)
Bozordan keyin: Aug 5, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
0.28
+0.02 (7.83%)
Yopilishda: Aug 5, 2026, 4:00 PM EDT
0.30
+0.02 (5.82%)
Bozordan keyin: Aug 5, 2026, 7:59 PM EDT
AIM ImmunoTech Inc., immun-farmatsevtika kompaniyasi, Qoʻshma Shtatlarda turli turdagi saraton, virusli kasalliklar va immunitet tanqisligi buzilishlarini davolash uchun terapevtik vositalarni tadqiq qilish va ishlab chiqish bilan shugʻullanadi. Kompaniyaning asosiy mahsulotlari quyidagilardir: Ampligen (rintatolimod), surunkali charchoq sindromini davolash uchun katta makromolekulyar ikki zanjirli ribonuklein kislota molekulalaridan iborat dori; va Alferon N Injection (Interferon alfa), genital siğillarni davolash uchun tozalangan, tabiiy manbali, glyukozilangan, koʻp turlardan olingan alfa-interferon mahsuloti. Kompaniya, shuningdek, Ampligenni oshqozon osti bezi, buyrak hujayrali karsinoma, malign melanom, mayda hujayrali oʻpka, tuxumdon, koʻkrak bezi, yoʻgʻon ichak va prostata saratoni, shuningdek, miyalgiya ensefalomieliti, Gepatit B, OIV, COVID-19 va post-COVID holatlarini davolash uchun ishlab chiqmoqda. Kompaniya ilgari Hemispherx Biopharma, Inc. nomi bilan tanilgan va 2019-yil avgust oyida AIM ImmunoTech Inc. nomini oʻzgartirgan. AIM ImmunoTech Inc. 1966-yilda tashkil etilgan va shtab-kvartirasi Florida shtatining Ocala shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Ann Marie E. Coverly | Director of Administration & Human Resources and Deputy Investor Relations Coordinator |
| Dr. Christopher Nicodemus FACP, M.D. | Member of Scientific Advisory Board & Consulting Science Officer |
| Mr. Peter W. Rodino III, Esq., J.D. | COO, Executive Director of Governmental Relations, General Counsel & Secretary |
| Mr. Robert Dickey IV, B.A., M.B.A. | Chief Financial Officer |
| Mr. Thomas K. Equels Esq., J.D., M.S. | Executive Vice Chairman, CEO & President |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-07-16 | 8-K | form8-k.htm |
| 2026-07-09 | S-8 | forms-8.htm |
| 2026-06-25 | DEF 14A | formdef14a.htm |
| 2026-06-18 | S-1 | forms-1.htm |
| 2026-06-18 | CORRESP | filename1.htm |
| 2026-06-15 | PRE 14A | formpre14a.htm |
| 2026-06-15 | CORRESP | filename1.htm |
| 2026-06-15 | 8-K | form8-k.htm |
| 2026-06-11 | 8-K | form8-k.htm |
| 2026-06-10 | 8-K | form8-k.htm |